These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 3010363)

  • 1. A late-appearing benzodiazepine-induced hypoactivity that is not reversed by a receptor antagonist.
    Lister RG; File SE
    Psychopharmacology (Berl); 1986; 88(4):520-4. PubMed ID: 3010363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mice and rats are sensitized to the proconvulsant action of a benzodiazepine-receptor inverse agonist (FG 7142) following a single dose of lorazepam.
    Lister RG; Nutt DJ
    Brain Res; 1986 Aug; 379(2):364-6. PubMed ID: 3017512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recovery from lorazepam tolerance and the effects of a benzodiazepine antagonist (RO 15-1788) on the development of tolerance.
    File SE
    Psychopharmacology (Berl); 1982; 77(3):284-8. PubMed ID: 6126909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of the benzodiazepine receptor in mediating long-lasting anticonvulsant effects and the late-appearing reductions in motor activity and exploration.
    File SE; Wilks LJ; Mabbutt PS
    Psychopharmacology (Berl); 1989; 97(3):349-54. PubMed ID: 2541459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic treatment with Ro 15-1788 distinguishes between its benzodiazepine antagonist, agonist and inverse agonist properties.
    File SE; Dingemanse J; Friedman HL; Greenblatt DJ
    Psychopharmacology (Berl); 1986; 89(1):113-7. PubMed ID: 3090585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The anxiolytic but not the sedative properties of tracazolate are reversed by the benzodiazepine receptor antagonist, Ro 15-1788.
    File SE; Pellow S
    Neuropsychobiology; 1985; 14(4):193-7. PubMed ID: 2872613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does the behavioural activation detected after a single dose of a benzodiazepine reflect a withdrawal response?
    Wilks LJ; File SE
    Life Sci; 1988; 42(23):2349-57. PubMed ID: 3131607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic benzodiazepine administration: from the patient to the gene.
    Miller LG
    J Clin Pharmacol; 1991 Jun; 31(6):492-5. PubMed ID: 1652596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The benzodiazepine antagonist Ro 15-1788 reverses the effect of methyl-beta-carboline-3-carboxylate but not of harmaline on cerebellar cGMP and motor performance in mice.
    Burkard WP; Bonetti EP; Haefely W
    Eur J Pharmacol; 1985 Feb; 109(2):241-7. PubMed ID: 2986997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrinsic actions of benzodiazepine antagonists.
    File SE; Lister RG; Nutt DJ
    Neurosci Lett; 1982 Oct; 32(2):165-8. PubMed ID: 6292797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What can be learned from the effects of benzodiazepines on exploratory behavior?
    File SE
    Neurosci Biobehav Rev; 1985; 9(1):45-54. PubMed ID: 2858081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of the specific benzodiazepine antagonist, Ro 15-1788, in studies of physiological dependence on benzodiazepines.
    Cumin R; Bonetti EP; Scherschlicht R; Haefely WE
    Experientia; 1982 Jul; 38(7):833-4. PubMed ID: 6809488
    [No Abstract]   [Full Text] [Related]  

  • 13. The NMDA receptor competitive antagonist CPP modulates benzodiazepine tolerance and discontinuation.
    Koff JM; Pritchard GA; Greenblatt DJ; Miller LG
    Pharmacology; 1997 Nov; 55(5):217-27. PubMed ID: 9399331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bidirectional effects of benzodiazepine receptor ligands against picrotoxin- and pentylenetetrazol-induced seizures.
    Jensen LH; Petersen EN
    J Neural Transm; 1983; 58(3-4):183-91. PubMed ID: 6319592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of Ro 15-1788 on anxiolytic self-administration in the rhesus monkey.
    Johanson CE; Schuster CR
    Pharmacol Biochem Behav; 1986 Apr; 24(4):855-9. PubMed ID: 2872684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The benzodiazepine antagonist Ro 15-1788 does not antagonize the ethanol withdrawal syndrome.
    Adinoff B; Majchrowicz E; Martin PR; Linnoila M
    Biol Psychiatry; 1986 Jun; 21(7):643-9. PubMed ID: 3011130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discriminative stimulus effects of atypical anxiolytics in baboons and rats.
    Ator NA; Griffiths RR
    J Pharmacol Exp Ther; 1986 May; 237(2):393-403. PubMed ID: 2871171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The anxiogenic action of RO 5-4864 in the social interaction test: effect of chlordiazepoxide, RO 15-1788 and CGS 8216.
    File SE; Pellow S
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Jan; 328(3):225-8. PubMed ID: 2984580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic benzodiazepine administration. XI. Concurrent administration of PK11195 attenuates lorazepam discontinuation effects.
    Byrnes JJ; Miller LG; Perkins K; Greenblatt DJ; Shader RI
    Neuropsychopharmacology; 1993 May; 8(3):267-73. PubMed ID: 8389555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of lorazepam tolerance and withdrawal on GABAA receptor-operated chloride channels.
    Allan AM; Baier LD; Zhang X
    J Pharmacol Exp Ther; 1992 May; 261(2):395-402. PubMed ID: 1374467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.